I was involved in a malpractice case a couple of years ago as a consultant. The case involved an emergency physician who was being sued for failure to make a rapid diagnosis of an ST-segment elevation ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

Background Despite advances in acute coronary syndrome (ACS) management, contemporary data assessing long-term prognosis ...

The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 ...

Boone Health renewed its Level I STEMI Center status, Missouri’s highest recognition for heart attack care.

It may be safe to omit stenting in some STEMI patients who have adequate flow restored and minimal residual stenosis, according to a look back at data from the DANAMI3-DEFER trial. Yet researchers ...

Just one in three North American patients admitted to the cardiac intensive care unit (CICU) for STEMI complicated by cardiogenic shock (STEMI-CS) would meet the high bar set for entry into the DanGer ...

Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says. STEMI (ST‐segment-elevation myocardial infarction) heart attacks have declined by nearly 50% during ...

Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate significantly higher one-year mortality rates in patients with COVID-19 and ST-elevation myocardial ...